Progyny, Inc. (PGNY)

↓ Download CSV

CIK 0001551306 · Nasdaq · Services-Misc Health & Allied Services, NEC

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Progyny, Inc. reported revenue of $1.29B, up 10.4% from the prior year. The company was profitable, with a net margin of 4.5% and a gross margin of 23.6%. It held $742.43M in total assets against $226.39M in total liabilities.

Key ratios (FY2025)

23.6%
Gross margin
6.6%
Operating margin
4.5%
Net margin
11.3%
Return on equity
+10.4%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$1.29B$1.17B$1.09B$786.91M$500.62M$344.86M
Cost of Revenue$984.18M$913.86M$849.80M$619.59M$388.49M$274.80M$184.18M$85.97M$41.18M
Gross Profit$304.48M$253.36M$238.80M$167.32M$112.14M$70.06M$45.51M$19.43M$7.40M
Operating Income$85.28M$67.45M$62.18M$23.34M$32.34M$8.35M$9.68M-$3.45M-$11.01M
Net Income$58.52M$54.34M$62.04M$30.36M$65.77M$46.46M-$8.57M$661.0K-$12.45M
EPS (Diluted)$0.65$0.57$0.62$0.30$0.66$0.47$-0.41$0.04$-2.37
Total Assets$742.43M$607.10M$756.62M$542.99M$358.06M$253.93M$150.43M$41.32M
Total Liabilities$226.39M$185.04M$203.19M$166.02M$106.24M$86.98M$36.16M$30.20M
Shareholders' Equity$516.04M$422.06M$553.43M$376.97M$251.82M$166.95M$114.27M-$95.11M-$97.62M
Cash & Equivalents$112.24M$162.31M$97.30M$120.08M$91.41M$70.31M$80.38M$127.0K
Operating Cash Flow$210.19M$179.10M$188.81M$80.39M$26.04M$36.20M-$1.53M$2.27M-$9.47M
Capital Expenditures$18.41M$5.41M$3.64M$3.24M$2.13M$1.04M$2.96M$579.0K$612.0K
Shares Outstanding89.86M95.45M100.67M99.96M100.36M99.06M20.74M5.54M5.68M